Because betulin inhibits ABL1, a kinase shown to cause chronic myelogenous leukemia (CML) when deregulated by fusion with BCR, we next used the human K562 CML cell line to test the effects of betulin in cultured cells (Figure 5a). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.